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Hantaan virus (HTNV) causes hemorrhagic fever with renal syndrome (HFRS), which is a
zoonosis endemic in eastern Asia, especially in China. The reservoir host of HTNV is field
mouse (Apodemus agraricus). The main manifestation of HFRS, including acute kidney
injury, increases vascular permeability, and coagulation abnormalities. In this paper,
we review the current knowledge of the pathogenesis of HFRS including virus factor,
immunity factor and host genetic factors. Furthermore, the treatment and prevention will
be discussed.
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INTRODUCTION
Hemorrhagic fever with renal syndrome (HFRS) has been a major epidemic mainly in Asia and
Europe. About 100,000 cases of HFRS are documented annually (Zhang et al., 2008), most of which
occurred in China, Korea, and Russia (Yu et al., 2014). In northern Europe, mostly in Sweden and
Finland, the case-fatality rate of nephropathis epidemica (NE) was 0.1–1% (Hjertqvist et al., 2010).
SEOV causes HFRSwith amortality rate of 1% (Saksida et al., 2011). Among all the countries, China
is the most seriously affected one which accounts for over 90% of the total HFRS cases around the
world (Khaiboullina et al., 2005a; Jonsson et al., 2010). During 1950–2014, a total of 1,625,002 cases
and 46,968 deaths were reported in China, with the death rate of 2.89%, according to the statistical
data from the national health and Family Planning Commission of China.
HFRS is caused by Hantaan virus (HTNV), Amur virus(AMV), Seoul virus (SEOV), Dobrava
virus (DOBV), or Puumala virus (PUUV), each of which causes diseases with differing severity.
HTNV or DOBV may cause the most severe form of HFRS and have the highest morbidity rates
ranging from 5 to 10% (Jonsson et al., 2010) SEOV is globally widespread and may cause moderate
HFRS; PUUV is endemic in northern Europe and may cause a generally mild form of HFRS, which
is also called NE. Sin Nombre virus (SNV), which belongs to the same genus as the former ones
which is Hantavirus, is associated with a severe form of hantavirus cardiopulmonary syndrome
(HCPS).
Hantavirus mainly infects human vascular endothelial cells and causes extensive damage in
capillaries and small vessels. However, the explanation of the pathogenesis of HFRS is far from
enough. One of the reasons is the lack of suitable animal models. Recently, many basic and clinical
studies are shedding light on its underlying mechanisms and suggesting various means to reduce
the severity of illness. In this paper, we review investigations of the pathogenesis of HFRS and
speculate on directions for future studies. We will first introduce basic information of hantaviruses,
and then the rodent reservoirs and routes of transmission to humans. After that, we will summarize
the clinical features of HFRS and review the major pathogenesis, mainly focusing on the role of
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innate and adaptive immune responses in producing vascular
leakage, coagulation defects and other features of the disease.
Finally, we will discuss the recent advances in treatment, and
focus on some new treatments that could reduce deleterious host
responses to infection.
HANTAVIRUSES AND THEIR RESERVOIR
HOSTS
HTNV is an enveloped virus, with a negative-sense RNA genome,
which belongs to the Hantavirus genus within the family of
Bunyaviridae (Kaiwa et al., 2007). The virus particle is oval
or spherical in shape with a diameter ranging from 80 to
120 nm. The genome of HTNV-RNA consists of three segments
designated S [small: 1700–2100 nucleotides(nt)], M(medium:
3600–3700 nt), and L(large: ∼6500 nt). The S segment encodes
the nucleocapsid protein; the M segment encodes envelope
glycoproteins (G1 and G2); L segment encodes the RNA-
dependent polymerase protein (Jiang et al., 2008; Hall et al.,
2010). HTNV is very stable and can remain infective for 2 weeks
at room temperature and presumably for more time at lower
temperature.
HTNV and SEOV are two serotypes in China, with the main
natural hosts being Apodemus agrarius and Rattus norvegicus,
respectively (Zhang et al., 2014a). These reservoir animals are
asymptomatic after infection because the hantaviruses have
developed different escape mechanisms against the innate
immune system during the long lasting co-evolution within these
different hosts species (Rang, 2010).
The main transmission pathway from rodents to humans
is aerosolized excreta inhalation and contact infection. Person-
to-person transmission has not been found. Rural areas, with
poor housing conditions and high rodent density, accounts for
more than 70% of HFRS cases, and the majority of infected
cases are local farmers (Zhang et al., 2010). Forest workers,
shepherds, woodcutters and military personnel also have high
occupational hazard from HTNV infection in that epidemiologic
investigations have linked virus exposure to such activities as
heavy farm work, threshing, sleeping on the ground and military
exercises (Schmaljohn and Hjelle, 1997).
HFRS mostly occurs in the period from the late autumn to
the next spring, with two incidence peaks (Liu et al., 2007).
The starting time of HFRS incidence peak depends on the
TABLE 1 | Typical clinical phases, symptoms and complications of HFRS.
Phase of illness Febrile Hypotensive Oliguric Polyuric Covalescent
Time of occurence 1∼7 days 1∼3 days 2∼6 days 2 weeks 3∼6 months
Principal features Fever Hypotension Urine output decreased Urine output increased
Signs and symptoms Headache Capillary leakage Anuria (urine output <100ml/day) Weight decrease Weakness
Vomiting Pulmonary symptoms Fluid retention Fatigue
Abdominal pains
Back pains
Visual disturbances
Complications Acute encephalomyelitis, Bleedings, Multiorgan failure, Pituitary hemorrhage, Glomerulonephritis, Pulmonary edema, Shock, ARDS, DIC
type of pathogenic hantavirus and also coincides with increased
human outdoor activities in spring and fall. The scale of rodent
populations may also affect the disease outbreaks in humans
(Khaiboullina et al., 2005a). SEOV is the major hantavirus that
circulates in the domestic rats and causes human infection in
urban areas. SEOV-caused HFRS mainly occurs in spring.
GENERAL FEATURES OF HEMORRHAGIC
FEVER WITH RENAL SYNDROME
The clinical course of HFRS is primarily characterized by
fever, circulatory collapse with hypotension, hemorrhage, and
acute kidney injury (AKI). The disease typically progresses
through five phases: febrile, hypotensive shock, oliguric, polyuric,
and convalescent (Table 1). Additionally, some of these phases
frequently overlap in severe cases, and one or two phases
are frequently absent in some mild cases. Laboratory findings
during acute stage of the disease are anemia, leukocytosis,
thrombocytopenia, elevated liver enzymes, and serum creatinine
(renal dysfunction), as well as proteinuria and hematuria.
Most of the cases can recover completely, while some severe
cases still have some sequelaes including headache, insomnia,
hyperhidrosis, hemorrhage, and hyperdiuresis.
Kidney injury frequently occurs in HFRS and the most
prominent pathological presentation is acute tubulointerstitial
nephritis following the infiltration of inflammatory cells (Kim
et al., 2010). AKI often induces death in patients with HFRS,
particularly in the oliguric phase (Wang et al., 2013). The
elderly patients often develop severe AKI and are more likely
to have shock, hematuria, thrombocytopenia and leukocytosis.
The patients with severe AKI usually need dialysis or continuous
blood purification and stay longer in hospital than non-AKI
patients (Wang et al., 2013).
Thrombocytopenia, which is one of the factors that cause
the increase of blood vessel permeability, is related to severe
AKI among patients with acute HTNV infection. Acute
thrombocytopenia is a common symptom of HFRS and persists
throughout hantavirus infection. Therefore, thrombocytopenia is
an important basis for the diagnosis of HFRS (Denecke et al.,
2010).
Pulmonary, cardiac, endocrinological, central nervous system,
and ocular findings are also major manifestations of HFRS. The
febrile, hypotensive, and oliguric phases can overlap in some
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severe cases. In this condition, acute progressive noncardiogenic
pulmonary edema, which often presents as acute respiratory
distress syndrome (ARDS), is likely to happen, and, thus, results
in a high fatality rate. It was demonstrated that the agitation,
conjunctival hemorrhage, coma, were also negatively correlated
with survival outcome (Du et al., 2014a).
The diagnosis of HFRS is based on exposure history, typical
clinical manifestations, and serum test results, such as the
detection of IgM or IgG antibodies against hantavirus in patient
serum by enzyme-linked immunosorbent assay (ELISA) and
colloidal gold method. A safe, rapid and specific serotyping
method for diagnosis was developed by using the recombinant
hantavirus nucleocapsid protein (NP) as antigen (Li et al., 2006).
It has been demonstrated that the detection of NP-specific IgM
antibodies in clinical samples is a good indicator of a recent
hantavirus infection (Peters and Khan, 2002). The detection
of hantavirus-specific IgM in an ELISA format is the most
valuable and widely used method for diagnosing acute hantavirus
infections (Li et al., 2002). Truncated recombinant NP detection
has been shown to be more specific to differentiate the involved
hantavirus serotype (Araki et al., 2001). However, ELISA and
other serological tests cannot be used to assess the replication
of the virus in patient’s blood. Several methods for detection of
HTNV in cell culture supernatant or blood sample have also
been developed. Plaque assay is a classical method to titrate
virus. However, it usually takes 5–7 days for the formation of
the viral plaques. Recently, a SYBR Green I based real-time PCR
assay targeting the S segment of the HTNV genome for the
detection of virus in cell supernatant was developed (Jiang et al.,
2014).
PATHOGENESIS OF HFRS
HFRS has been widely believed as one type of systemic
inflammatory response syndrome, and the patient’s
pathophysiologic manifestations of the hypotensive phase
are similar to those of typical distributive shock. Vascular
endothelial dysfunction is the basic pathological change,
which is characterized by dramatic increase in vascular
permeability (Grvrilovskaya et al., 2008; Gorbunova et al.,
2011). Increased vascular permeability leads to plasma
exosmosis and even hemorrhage, which is associated with
lots of clinical features in HFRS, such as hemoconcentration,
hypotension, shock, and abdominal pains (Hayasaka et al.,
2007) (Figure 1). So far, it is difficult to explain the
pathogenesis in a single factor. Studies have suggested
that HFRS may be developed via indirect mechanisms
including the virus factors, immune factors and host genetic
factors.
Virus Factor
HFRS is characterized by increased vascular permeability
and coagulation disorders. It was recognized that human
endothelial cells isolated from both adult and fetal veins
are highly susceptible to the HTNV infection. However,
in vitro infection with HTNV does not cause any noticeable
cytopathic effect, as judged by both phase microscopy and
FIGURE 1 | Left side: Normal endothelial cells (EC), no vascular leakage
occurs. Right side: EC were infected with hantaviruses. ZO-1, VEGFR2,
VE-cadherin on EC were altered. High hantavirus RNA load result in severe
vascular leakage. Virus-infected ECs be cleared by virus-specific CTLs leading
to vascular damage. Owing to acute thrombocytopenia, there are not sufficient
platelets available to repair “holes” in the EC barrier, resulting in vascular
leakage. In addition, cytokines produced during the innate response against
pathogenic hantaviruses like TNF-α could enhance vascular permeability.
electron microscopy (Pensiero et al., 1992). Therefore,
hantavirus is considered to be a non-cytopathogenic virus
which targets primarily vascular endothelial cells (Guhl et al.,
2010).
It has been demonstrated that there is an association between
the hantavirus RNA load and disease severity in some recent
studies. An increased Sin Nombre viral load is likely to produce a
more severe clinical outcome (Xiao et al., 2006). HTNVRNA load
in plasma in patients during the early stages of HFRS is associated
with disease severity (Yi et al., 2013). Close correlation between
viral load and disease severity were also found in cases of DOBV
(Saksida et al., 2008).
It has been suggested that the cell permeability induced
by hantavirus infection is associated with impaired barrier
structure. An analysis of renal biopsy specimens from hantavirus-
infected patients revealed that the expression and the localization
of the tight junction protein ZO-1 were altered compared
to renal biopsy specimens from non-infected individuals,
that both tubular and glomerular cells were affected by
the infection, and that the decrease in glomerular ZO-
1 correlated with disease severity induced by glomerular
dysfunction (Krautkrämer et al., 2011). It was reported that
increased secreted vascular endothelial growth factor (VEGF)
and concomitant decreased VE-cadherin were detected during
the early stages in human primary lung endothelial cells
infected by Andes virus (Shrivastava-Ranjan et al., 2010).
The study also found that active virus replication could
produce increased permeability and decreased the integrity
of the endothelial cell barrier. Another study found that
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VEGF binding to VEGF receptor 2 (VEGFR2) may result
in dissociation of VEGF-R2 from VE-cadherin, VE-cadherin
activation, internalization, and degradation, that VEGF addition
to ANDV- and HTNV-infected endothelial cells may induce
the hyperphosphorylation of VEGFR2, and that concomitant
with the VEGFR2 hyperphosphorylation, VE-cadherin may be
internalized to intracellular vesicles within ANDV- or HTNV-
infected endothelial cells (Gorbunova et al., 2010). Wang
et al. (2012b) found the interaction between β3 integrin and
VEGFR2 and the formation of a functional complex and
that the signaling through this complex caused cytoskeletal
reorganization, which was an important mechanisms underlying
hyperpermeability. They also found that VEGF remarkably
enhanced HTNV-directed permeability and the disruption of
junctional organizations in an endothelial cell (EC) monolayer
at 3 days postinfection.
Immunity Factor
Similar to the effects of many other pathogenic viruses, HFRS
is mainly medicated by the efforts of the immune system, both
innate, and adaptive, to clear the infection. Therefore, it has
been widely accepted that HFRS pathogenesis is largely immune
mediated, including immune complexes, complement activation,
T cell response, B cell response, and HTNV-induced cytokine
production (Khaiboullina et al., 2005b; Easterbrook et al., 2007)
(Figure 2).
FIGURE 2 | Monocytes, macrophages, NK cells, and Lymphocytes
produce various cytokines/chemokines which directly or indirectly
increase vascular permeability. The humoral pattern recognition receptor
PTX3 and antibodies activate complement. Activated complement
components induce cytoskeletal rearrangement in EC further increasing
dysfunction of the EC barrier. TLRs recognize Hantavirus and mediate the
innate response. Virus-infected ECs were cleared by virus-specific CTLs
leading to vascular leakage. B cells produce several subclass antibodies, while
only the neutralizing antibodies against G1 and G2 is beneficial to decrease
the viruses, then decrease vascular leakage.
Role of Innate Immune Response
TLRs
Innate immunity works like a sentinel againstmicrobial pathogen
invasion. Innate immunity can be activated immediately
following the recognition of diverse Pathogen-associated
molecular patterns (PAMPs) by various Pattern-recognition
receptors (PRRs). Among the different receptors that participate
in the recognition of microbial invaders, Toll-like receptors
(TLRs) play important roles in mediating the innate response
(Akira et al., 2006). TLRs can produce effective immune
responses and trigger the release of inflammatory cytokines
and type I interferon for host defense (Beutler, 2009). Handke
et al. (2009) found that HTNV may trigger TLR3-dependent
innate immune response. In Jiang et al.’s study (2008), five
TLRs (TLR2, TLR3, TLR4, TLR7, and TLR9) were detected in
HTNV-infected vascular endothelial cells; however, only the
expression of TLR4 was up-regulated. They also found that TLR4
may mediate the up-regulated expression of TNF-α, interferon-β
(IFN-β) and IL-6 in HFRS. Zhang et al. (2014b) found that
HTNV, a single-strand RNA virus, can act as a double-strand
RNA to activate the TLR, retinoic acid inducible gene I (RIG-I)
and MDA-signaling pathways, that NF-κB and IRF, activated
through the downstream transcription factors of these pathways,
bound directly to the CXCL’s promoter, which then increased
the expression of CXCL, and that RANTES and IP-10 have been
detected altered after HTNV infection.
Cytokines/chemokines
The overproduction of inflammatory cytokines is commonly
reported in subjects with HFRS and has given rise to the
hypothesis that a so-called “cytokine storm” may play a pivotal
role in the pathogenesis of the disease. Vaheri et al. (2013)
found that these molecules were produced by various cells,
such as macrophages, monocytes, and lymphocytes, in response
to pro-inflammatory signals and participate in the regulation
of inflammation. Wang et al. (2012a) reported that the serum
concentrations of TNF-α, IL-6, IFN-γ, IL-8, IP-10, and RANTS
(but not IL-4) were remarkably higher in HFRS patients,
compared with controls, and that the highest concentrations
were usually found during the febrile, hypotensive, and oliguric
phases, particularly in severe and critical-type HFRS cases.
Increased levels of cytokines and chemokines and an imbalance
in their production contribute to increasing vascular endothelial
permeability and a severe clinical course in patients with HFRS.
Lohoff and Mark (2005) suggested that cytokines, such as TNF-
α, IL-6 and IL-1, were mediators inducing fever, septic shock
and acute phase protein production, and that TNF-α, IFN-β, and
IL-6 were important cytokines which were responsible for the
increased permeability of endothelial cells.
Overproduction of TNF-αmay lead to severe systemic toxicity
and has to do with the symptoms of HFRS. TNF-α treatment
of endothelial cells in vitro may lead to increased endothelial
cell monolayer permeability without visible cytopathic effect. In
Linderholm et al. study (1996), the level of TNF-α was found
to be increased in plasma during the acute stage of hantavirus
infection. However, Khaiboullina et al. (2000) found that TNF-α
level did not change in SNV-infected cells and that supernatants
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from SNV-infected human alveolar macrophages did not induce
an obvious increase in endothelial monolayer permeability.
It was reported that the levels of VEGF were closely correlated
to the progression of HFRS. Moreover, elevated levels of VEGF
have correlation with the severity and degree of kidney damage
(Li et al., 2013). The β3 integrins regulate vascular permeability
through effects on VEGF (Dvorak, 2006). The αvβ3 works
coordinately with VEGF to direct endothelial cell migration
during angiogenesis and to reseal the endothelium in response
to damage (Byzova et al., 2000).
Type I IFNs (IFNα/β) are cytokines which are produced
in response to viral infection and play an important role
in regulating viral replication. In vivo and in vitro studies
demonstrated that higher levels of IFNβ occurred in the serum
of HFRS patients and in hantavirus-infected cell (Murzabaeva,
2002; Jiang et al., 2008). It was reported that serum level of IFN-
γ was upregulated in HFRS cases when compared to healthy
controls and the level of upregulation is dependent on the phase
and severity of the disease (Khaiboullina et al., 2014). They also
observed an association between the mild form of the disease
and elevated serum levels of IFN-γ and IL-12. Collectively, these
observations indicate that the administration of exogenous IFN-
γ and IL-12 may provide antiviral benefits for the treatment of
HFRS. Thus, regulating the early IFN response is necessary for
hantaviruses to replicate in human endothelial cells and to be
pathogenic.
The IFN-inducible MxA is considered to be important
for control of infections with hantaviruses. MxA inhibits
representativemembers of the Bunyaviridae family by interacting
with an early step of virus replication. MxA protein can inhibit
PUUV and Tula virus (TULV) replication in both viral protein
and RNA accumulation in virus-infected cells (Kanerva et al.,
1996). When constitutively expressed in stably transfected Vero
cells, MxA prevented the accumulation of viral transcripts and
proteins of Hantaan virus (Frese et al., 1996). It was suggested
that MxA endogenously expressed in response to type I or type
II IFNs does not play a pivotal role in the antiviral process
against HTNV and that there is more than one mechanism by
which cellular defense blocks hantavirus replication (Oelschlegel
et al., 2007). Khaiboullina et al. (2005b) found in their study that
MxA inhibited production of new infectious virus particles by
interacting with the virus nucleocapsid protein.
Several other cytokines also have relationship with the
symptoms of HFRS. IL-6, IL-10, VEGF, TNF, and cytotoxic T cell-
mediatedmechanisms are associated with the symptoms of HFRS
(Hayasaka et al., 2007; Gavrilovskaya et al., 2008). Increased levels
of IL-6, TNF, IL-1, IL-8, IFN-γ, IP-10, and CCL5 were found
in vivo and in vitro (Saksida et al., 2011; Wang et al., 2012a).
High plasma IL-6 levels are associate with severe renal failure and
thrombocytopenia in PUUV-induced HFRS and can be looked
as a marker of disease severity (Outinen et al., 2010). Increased
levels of IL-10, INF-γ and TNF-α were observed in most HFRS
patients infected by DOBV. Moreover, the concentrations in
patients infected with DOBV are higher than in patients infected
with PUUV on average (Saksida et al., 2011).
To sum up, inflammatory cytokines/chemokines produced
by the antiviral innate response is like a double edged sword.
On the one hand, they are helpful in eliminating viruses
directly or indirectly by inducing innate effector functions
and antigen presentation of viral epitopes to T cells. On the
other hand, inflammatory cytokines/chemokines may facilitate
immunopathological processes in virus-associated diseases.
Complement
It has been proposed that the complement system is associated
with hantavirus-induced immunopathology. The soluble form
of the terminal complement membrane attack complex, SC5b-
9, can increase the permeability of cultured endothelial cells
(Bossi et al., 2004). In the acute phase of PUUV infection, the
complement system becomes activated and the severity of disease
varies directly as the levels of complement activation (Sane
et al., 2012). The acute phase protein pentraxin-related protein 3
(PTX3), whichmediated the complement activation in the course
of hantavirus infection, is increased during the acute phase of
PUUV infection (Outinen et al., 2012).
NK cell
Natural killer cells also participate in the pathology and the
capillary leak syndrome in HFRS (Björkström et al., 2011).
Monocytes and Macrophages put up a bridge between innate
and adaptive immunity. High expression of cytokines activating
in the early phase of HFRS contribute to the immune-mediated
pathogenesis (Mustonen et al., 2013).
ROLE of Cellular Immune Response
B cell response
IgM response. IgM antibody is against all the three structural
proteins of hantavirus. Shortly after the onset of the disease,
activation of the humoral immune response will often result in
formation of IgM. HFRS patients are characterized by high levels
of hantavirus IgM detected simultaneously with the onset of
clinical symptoms. Serum levels of IgM will reach the maximum
7–11 days after initial symptoms. In the convalescent phase of the
HFRS, the levels of the IgM usually decline meanwhile the levels
of IgG rise (Khaiboullina et al., 2005a). Therefore, it is often used
as a diagnosis index for HFRS.
IgG subclass antibodies. The levels of IgG1 and IgG3, often
increase with progression of the disease. However, IgG2 normally
remains at more or less the same level in HFRS patients
(Lundkvist et al., 1993). During the convalescent phase of HFRS,
IgG3 against hantavirus N and G1 proteins often reach the
highest peak and then decline gradually in the future decades.
There is no direct relationship between the severity of the disease
and levels of IgG subclasses. Recent years, there is too few
further study about IgG antibodies and the knowledge about IgG
antibodies is still limited.
IgA response. IgA plays an important role in mucosal immunity,
and aerosol is an important way of the spread of hantavirus.
Therefore, the presence of neutralizing IgAmay play a significant
role in the recovery from acute infection and in long-term
immunity. The highest levels of anti-PUUV IgA can be detected
in the sera of acute and early convalescent phase. With the
progression of the disease, the levels of IgA will gradually
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decrease. Thus, IgA antibody is regarded as themarker of an early
stage of infection (Nicacio et al., 2000). However, themechanisms
involved in IgA anti-viral protection remain unclear.
IgE response. High levels of hantavirus-specific and total IgE
can be detected in serum during the acute phase of the disease.
They usually gradually decline with the progression of the disease
(Alexeyev et al., 1994). Though hantavirus infection significantly
induced increased serum levels of IgE, the levels of virus specific
IgE were not correlated with the severity of the disease (Alexeyev
et al., 1994). Further investigations need to be focused on the
function of IgE in the pathogenesis of HFRS.
Neutralizing antibodies. G1 and G2 glycoproteins are accepted
as the major antigens involved in induction of neutralizing
antibodies during hantavirus infection. It was demonstrated
in vitro that Monoclonal antibodies (MAbs) directed against G1
and G2 displayed neutralizing activity, while the MAbs against
N protein did not (Xu et al., 2002). Therefore, MAbs against G1
or G2 have potential possibility to be used as a powerful agent to
neutralize virus in patients during early phases of HFRS.
T Cell Response
T cells have a two-sided role in viral infections. On the one
hand, they are essential components of the host defense against
intracellular pathogens, and on the other hand, they are often at
least partly responsible for the organ damage and symptomatic
disease caused by viruses. Both roles have been demonstrated
in murine models, but data from primary human infections is
scare and conflicting (Rouse and Sehrawat, 2010). Regulatory T
cells contribute to increased amounts of TGF-β protein in the
lungs during persistent SEOV infection. Therefore, regulatory
T cells may contribute to subclinical pathologic observations
in rats during SEOV infection (Easterbrook et al., 2007). In
HCPS, hantavirus-specific T cell response positively correlated
with disease severity. While in HFRS there are different results
reported in different articles (Terajima and Ennis, 2011). Several
studies have linked increased immune activity, both innate
and adaptive, to a more severe disease (Outinen et al., 2012).
However, whether this is because the strong immune response is
harmful, or a severe infection induces a stronger immune is still
unclear.
Cell-mediated immunity appears to play a crucial role in the
immune pathogenesis of HFRS. Some kinds of immune cells,
particularly CD8+ T cells, may also involve in the pathogenesis
of Hantavirus infection. It has been found that infection with
HTNV results in CTL responses to immunodominant regions
on the NP (Wang et al., 2009b). Strong CD8+ T cell response
was observed in PUUV infected patients (Lindgern et al., 2011).
Levels of HTNV-specific CD8+ T lymphocytes in patients with
HFRS were associated with different phases of HFRS. In the
fever phase, it was significantly elevated. The levels of HTNV-
specific CD8+ T lymphocytes in PBMC of patients with HFRS
were negatively correlated with the levels of creatinine and
blood urea nitrogen in plasma (Xie et al., 2013). In persistently
infected mice, hantavirus strongly suppresses the production of
N-specific CD8+ T cells throughout the course of infection
(Taruishi et al., 2007). The CTL response was believed to
play an important role against viral infection, but only a few
HTNV epitopes recognized by the CTLs have been found.
Three novel CD8+ CTL epitopes, N197-205 (RYRTAVCGL),
N245-253 (KLLPDTAAV), and N258-266 (GPATNRDYL), were
confirmed on the nucleocapsid protein. The epitopes were
restricted by various HLA alleles including A11, A24, and B7.
They were highly conserved among the reported hantanviruses,
supporting their potential use in vaccine designs (Wang et al.,
2011).
In addition, the importance of Treg cells in infections is well
established, but in effect, all of the data on acute infections
comes from reservoir hosts (Keynan et al., 2008). On one hand,
Treg cells play a key role in maintaining host homeostasis by
limiting destructive inflammatory reactions and thus decrease
immunopathology during antiviral immune responses. On the
other hand, suppression of the host antiviral immune response
by Treg cells may induce viruses to persist in the host (Belkaid
and Rouse, 2005). It was reported that the frequency of
CD4+CD25high cells was decreased and inversely correlated
with disease severity in Chinese HFRS patients (Zhu et al.,
2009). Treg cells have also been proved to contribute to the
persistent asymptomatic carrier of hantaviruses in their rodent
hosts, by suppressing immune responses (Easterbrook et al.,
2007; Schountz et al., 2007). It was found that the best predictor
of severe clinical course in HFRS was the FOXP3+ Treg cell
response, suggesting that the role of Treg cells in acute human
hantaviral infections may be deleterious (Koivula et al., 2014).
Host Genetic Factors Influence the Clinical
Outcome
Interaction of Hataviurs and Host
Integrins are important for regulating vascular permeability
and migrating of endothelial cells. It has been demonstrated
that HFRS-causing hantaviruses, HTNV, SEOV and PUUV, gain
cellular entry via specific αvβ3 or αIIbβ3 integrins (Gavrilovskaya
et al., 1998; Mou et al., 2006). These integrins are heterodimeric
receptors composed of α and β subunits which can mediate
cell-to-cell adhesion and platelet aggregation. Endothelial cells
and platelets are prominent regulators of vascular functions
and integrins play key roles in barrier functions of these cells
(Peters and Khan, 2002). Most interestingly, pathogenic and non-
pathogenic hantaviruses use different integrin receptors. Human
integrins αIIaβ3 which isexpressedon platelets and αvβ3 which
is expressed on endothelial cells can mediate cellular entry of
HFRS- and HCPS- causing hantaviruses (Gavrilovskaya et al.,
2008). In contrast, non-pathogenic or low pathogenic prospect
hill virus (PHV) or TULV were found to enter the cell via
integrin α5β1 (Gavrilovskaya et al., 2002). It was found that
HTNV-infected endothelial cells specifically direct the adherence
of calcein-labeled platelets while cells comparably infected with
nonpathogenic TULV failed to recruit platelets to the surface of
endothelial cell (Gavrilovskaya et al., 2010).
Interaction of the host immune system and hantaviruses are
of great importance for hantavirus infection. The pathogenesis
of hantaviruses infection in humans is obviously affected by
immunological factors.
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Individual Susceptibility to Hantavirus
The severity of HFRS infected by HTNV is positively correlated
to the age of the patients (Du et al., 2014b). It was reported that
most deaths from the hantavirus disease NE occurred in older
persons, especially the patients >70 years of age (Hjertqvist et al.,
2010). In China, it was demonstrated that the case fatality rate
was higher among individuals ≥50 years of age than that among
the younger individuals (Klein et al., 2011).
It has been suggested that the frequency of infection is
generally higher in male patients. The reported overall male-
female ratio for NE cases was 1.52:1 in Sweden during 1997–2007
(Hjertqvist et al., 2010). The incidence rate of HFRS were
significantly higher among male individuals than among female
individuals for all ages in China during 2004–2008 (Klein et al.,
2011). However, in northern Sweden, the same number of
persons of either sex might be infected with PUUV (Ahlm et al.,
1994). Fortunately, the clinical outcome seemed not worse in
males. In China, it was illustrated that the case fatality rates
of HFRS were significantly lower among male patients than
among female patients 20–39 and ≥50 years of age (Klein et al.,
2011). The expression of the supposed PRRs of hantavirus differs
according to the sexes. Female patients infected with SEOV
express higher levels of Toll-like receptor (TLR-7), RIG-I and
IFN regulatory factor-7 (IRF-7) thanmale patients (Hannah et al.,
2008).
In humans, the clinical procedure of hantavirus infections
is affected by host genes (Vaheri et al., 2013). In China, HLA-
DRB1∗09 and HLA-B∗46-DRB∗09 haplotypes in patients with
HTNV-induced HFRS were significantly more frequent than the
controls (Wang et al., 2009a). In Finland, HLA alleles HLA-
B8, HLA-C4A∗Q0, and HLA-DRB1∗0301 were associated with
severe form of PUUV infection (Deter et al., 2008) while the
individuals withHLA-B27were oftenmild cases (Mustonen et al.,
1996). In the United States, the individuals with HLA-B∗3501
allele have a higher risk of severe SNV-induced HCPS (Terajima
and Ennis, 2011). In Belgian patients, low TNF transcription
(a polymorphism at position-238) was associated with severe
clinical course (Maes et al., 2006).
TREATMENT AND PREVENTION
Antiviarl Drugs
Several antiviral drugs, including IFN-α, steroids and
cyclophosphamide, have been used in clinical for various
effects. Ribavirin (1-beta-D-ribofuranosy 11,2,4-triazole- 3-
carboxamide) has been used in the treatment of HCPS and
HFRS (Huggins et al., 1991; Chapman et al., 1999). Clinical trials
have shown that, if begun early during clinical course, ribavirin
can be effective against hantaviruses causing HFRS (Moreli
et al., 2014). It was also reported that after the application
of ribavirin, the mortality of patients with HFRS showed a
significant increase but that of patients with HCPS not (Moreli
et al., 2014). However, another investigation demonstrated
that ribavirin needed using in the oliguric phase to prevent
mortality (Rusnak et al., 2009). Icatibant, a drug which blocks
the binding of bradykinin, might be effective in large numbers
of patients with PUUV and other hantavirus infection (Vaheri
et al., 2014).
Favipiravir (T-705, 6-fluoro-3-hydroxy-2-
pyrazinecarboxamide) was reported to have a high activity
against a panel of Bunyaviruses (La crosse, Punta Toro, Rift
Valley fever, sandfly fever viruses, SNV, Andes virus) by
cytopathic effect and virus yield reduction (Gowen et al., 2007;
Safronetz et al., 2013).
MAbs against HTNV have been developed. In China, a single-
dose intravenous injection of a murine MAb against HTNV was
developed and applied in healthy volunteers (Xu et al., 2009; Hall
et al., 2010). It has been demonstrated that the anti-HTNVMAbs
have anti-HTNV activity both in vitro and in vivo (Xu et al.,
2002). Therefore, Mabs could be an effective candidate for the
treatment of HFRS.
In addition, small molecule inhibitors of hantavirus infection
were also studied. For example, inhibitors targeting αvβ3
integrins may be used as antiviral agents (Hall et al., 2010). Other
small-molecule inhibitors which target VEGFR2 and SFK(Src
family kinases) signaling responses are able to inhibit ANDV-
induced endothelial cell permeability (Gorbunova et al., 2011).
However, the therapeutic potential of these compounds needs to
be further studied and refined both in vitro and in vivo.
Supportive Measures
The earlier the detection, the admission to ICU and the
supportive treatment, the greater the reduction of mortality
rate (Huggins et al., 1991). Maintaining fluid and electrolyte
balance is a crucial and fundamental treatment method. In
addition to rectifying kidney dysfunction, blood pressure and
oxygenation also need to be maintained according to the precise
monitoring of invasive or non-invasive homodynamics.
Platelet transfusions can be used in severe cases with
thrombocytopenia and obvious bleedings. Symptomatic
treatment is also necessary for patients with headache and back
pains.
Continuous renal replacement therapy (CRRT) has become
an important and widely used therapy for critical HFRS patients
accompanied with mutiorgan injury, ARDS, pulmonary edema,
fluid overload, severe electrolyte disturbances, cerebropathy, and
AKI. Intermittent hemodialysis (IHD) is often chosen as the first
choice by clinicians for AKI patients with stable hemodynamic
status and less potentially fatal complications.
SUMMARY
HTNV is a major agent causing HFRS. The disease is obviously
very complex. We think that the dysfunction of all the organs is
mainly due to the capillary leakage and further studies should be
emphasized on this aspect. Although the pathogenesis of HFRS is
still unclear, our understanding on this disease has improved in
recent years.
As the initial reason of the disease, the virus itself plays an
important role in the course of pathological development. With
the progress of the virus nucleic acid detection technology, it has
become more easy and accessible to detect hantavirus RNA and
structural protein in clinical cases. The role of virus in different
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clinical stages and whole disease process needs to be further
studied.
It has been widely accepted that the immune response
plays an important role in hantavirus pathogenesis. A number
of studies have focused on adaptive immunity in the past.
High levels of hantavirus specific antibodies and presence of
IC in the blood were detected. More and more scientists
have been paying attention to early activation of immune
response to hantavirus antigens. Recently, lots of studies
indicate that innate immunity stimulates adaptive immunity
as well as innate immunity itself has antiviral functions.
We believe that future efforts should be made to find the
mechanism of the innate immunity in the pathogenesis of the
disease.
Strong antiviral treatment has improved the prognosis
of many kinds of viral diseases. Therefore, a new potent
antiviral drugs against hantavirus should be developed.
It should be emphasized that more and more studies are
now focusing on the pathogenesis of increased capillary
leakage. This research direction may provide a great
inspiration for the searches on effective therapies and
exploring potential therapeutic targets. Further important
questions mainly refer to the identification of risk factors,
preventive measures and vaccination. Answers had better be
found through close cooperation from scientists of various
fields.
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